Revenue

Arctera shifts to a unified SaaS model, promising limitless scale for data compliance. What does this strategic pivot mean for enterprises and the market?

A traditional Chinese steel manufacturer is pivoting to the high-stakes world of clean energy. Can it transform its industrial might into a green future?

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

With 21% of voice actors reporting job losses to AI, a national association is taking its fight to D.C. to demand policy action and protect human creativity.

With compliance costs soaring, Spring Labs' $5M funding round will scale its AI agents to automate the execution of regulatory tasks for financial firms.

Forrester's new report highlights Airia as enterprises grapple with governing the new wave of autonomous, agentic AI systems that defy old rules.

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

From 90s trends to green innovations, Canada's top salon chain celebrates 35 years of style, sustainability, and putting its stylists first.

A new all-in-one system from Sweden's Multi4 Medical just won EU approval, allowing urologists to treat bladder cancer in minutes without surgery.

Following a record 10.7 million visitors, The Palm Beaches are unveiling a wave of new hotels, restaurants, and cultural hubs. But can the boom be sustained?

A historic 142 deals and $1.67 trillion in assets changed hands in Q1 2026, as private equity, tech, and global ambitions fuel a record consolidation wave.

Maine's tourism office is using AI to create personalized trip plans, guiding visitors to hidden gems and boosting local economies across the Pine Tree State.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.

A new national agreement brings QuVa Pharma's AI-powered drug diversion software to thousands of hospitals, promising a high-tech solution to a hidden crisis.

Viant's acquisition of TVision challenges industry giants by pricing TV ads on actual viewership, moving beyond impressions to verifiable human attention.

The global investment bank is buying the boutique firm behind landmark deals for Liverpool FC and the NY Mets to dominate the booming sports finance market.

A biotech firm is making waves with a non-viral, redosable gene delivery system showing promise for DMD and hemophilia, challenging the industry's reliance on viruses.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

Ottobock and Angel City Sports expand their partnership, using advanced tech and community events to build momentum for the LA28 Paralympic Games.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.